Seems a drug targetting similar area to us was on market approved a few years back. Luxturna from Spark. May have been mentioned before. All these drugs are close to $1 million per patient treated. Interesting that some claim to be one off treatments that fix the gene error causing the condition.
https://www.google.com/amp/s/www.bizjournals.com/philadelphia/news/2019/02/19/sales-of-philadelphia-born-gene-therapy-product.amp.html
Seems a drug targetting similar area to us was on market...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.050(4.35%) |
Mkt cap ! $699.9M | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.21 | $1.13 | $387.7K | 327.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 25000 | 1 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |